Ignite Creation Date:
2024-07-17 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06486441
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-27
Brief Title:
Study of Sacituzumab Govitecan Versus Treatment of Physicians Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy ASCENT-GYN-01GOG-3104ENGOT-en26
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
GS-US-682-6769
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| European Network of Gynaecological Oncological Trial Groups ENGOT | OTHER |
| GOG Foundation | NETWORK |